Total Payments
$2,496
2024 Payments
$1,584
Companies
11
Transactions
26
Payment Breakdown by Category
Food & Beverage$2,496 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,496 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $626.10 | 5 | $0 (2024) |
| Incyte Corporation | $525.35 | 4 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $246.45 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $242.13 | 2 | $0 (2024) |
| ABBVIE INC. | $212.84 | 5 | $0 (2024) |
| Amgen Inc. | $150.75 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $130.09 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $124.46 | 1 | $0 (2024) |
| LEO Pharma Inc. | $119.21 | 1 | $0 (2024) |
| Journey Medical Corporation | $95.26 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,584 | 18 | E.R. Squibb & Sons, L.L.C. ($514.52) |
| 2023 | $762.79 | 7 | Incyte Corporation ($261.08) |
| 2022 | $150.00 | 1 | Sun Pharmaceutical Industries Inc. ($150.00) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $139.29 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $149.31 | General |
| Category: Immunology | ||||||
| 08/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Inflammation | ||||||
| 06/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $105.13 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Dermatology | ||||||
| 06/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $111.80 | General |
| 06/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $92.13 | General |
| Category: Dermatology | ||||||
| 05/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $121.47 | General |
| Category: Dermatology | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $130.04 | General |
| Category: Immunology | ||||||
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $130.04 | General |
| Category: Immunology | ||||||
| 04/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Dermatology | ||||||
| 03/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $119.21 | General |
| Category: DERMATOLOGY | ||||||
| 01/17/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $95.26 | General |
| 11/16/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $124.40 | General |
| Category: Dermatology | ||||||
| 10/26/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $136.68 | General |
| Category: Dermatology | ||||||
| 10/12/2023 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: ACNE | ||||||
| 07/19/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $124.98 | General |
| 07/18/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $111.58 | General |
| Category: Immunology | ||||||
| 07/12/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: Inflammation | ||||||
About Dr. Jeffrey Bubley, MD
Dr. Jeffrey Bubley, MD is a MOHS-Micrographic Surgery healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2019. The National Provider Identifier (NPI) number assigned to this provider is 1376002675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Bubley, MD has received a total of $2,496 in payments from pharmaceutical and medical device companies, with $1,584 received in 2024. These payments were reported across 26 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,496).
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Bellaire, TX
- Active Since 03/16/2019
- Last Updated 05/23/2024
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1376002675
Products in Payments
- Sotyktu (Drug) $626.10
- OPZELURA (Drug) $525.35
- SKYRIZI (Biological) $187.38
- Otezla (Drug) $150.75
- COSENTYX (Drug) $124.46
- Zoryve (Drug) $121.47
- ADBRY (Biological) $119.21
- Winlevi (Drug) $92.13
- RINVOQ (Biological) $25.46
- DUPIXENT (Biological) $23.73
- AKLIEF (Drug) $18.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.